Should clinicians be concerned about the carcinogenic potential of tamoxifen?
- 31 December 1994
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (11) , 1714-1721
- https://doi.org/10.1016/0959-8049(94)00349-a
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomesCarcinogenesis: Integrative Cancer Research, 1994
- The Royal Marsden Hospital pilot tamoxifen chemoprevention trialBreast Cancer Research and Treatment, 1994
- Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 ratsBreast Cancer Research and Treatment, 1994
- Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450sCarcinogenesis: Integrative Cancer Research, 1994
- A current view of tamoxifen for the treatment and prevention of breast cancerBritish Journal of Pharmacology, 1993
- Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cellsCarcinogenesis: Integrative Cancer Research, 1992
- Tamoxifen: disease prevention or disease substitution?The Lancet, 1992
- Breast Cancer Prevention Study Initiated in ItalyJNCI Journal of the National Cancer Institute, 1992
- Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity a prospective study of 63 patientsCancer, 1992
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991